1、Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia
and high myopia and temporal trends from 2000 through 2050[ J].Ophthalmology, 2016, 123(5): 1036-42.Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia
and high myopia and temporal trends from 2000 through 2050[ J].Ophthalmology, 2016, 123(5): 1036-42.
2、Wang SK, Guo Y, Liao C, et al. Incidence of and factors associated
with myopia and high myopia in Chinese children, based on refraction
without cycloplegia[ J]. JAMA Ophthalmol, 2018, 136(9): 1017-1024.Wang SK, Guo Y, Liao C, et al. Incidence of and factors associated
with myopia and high myopia in Chinese children, based on refraction
without cycloplegia[ J]. JAMA Ophthalmol, 2018, 136(9): 1017-1024.
3、Flitcroft DI, He M, Jonas JB, et al. IMI - defining and classifying
myopia: a proposed set of standards for clinical and epidemiologic
studies[ J]. Invest Ophthalmol Vis Sci, 2019, 60(3): M20-M30.Flitcroft DI, He M, Jonas JB, et al. IMI - defining and classifying
myopia: a proposed set of standards for clinical and epidemiologic
studies[ J]. Invest Ophthalmol Vis Sci, 2019, 60(3): M20-M30.
4、Yam JC, Jiang Y, Tang SM, et al. Low-concentration atropine for myopia
progression (LAMP) study: a randomized, double-blinded, placebocontrolled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in
myopia control[ J]. Ophthalmology, 2019, 126(1): 113-124.Yam JC, Jiang Y, Tang SM, et al. Low-concentration atropine for myopia
progression (LAMP) study: a randomized, double-blinded, placebocontrolled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in
myopia control[ J]. Ophthalmology, 2019, 126(1): 113-124.
5、Wildsoet CF, Chia A, Cho P, et al. IMI - interventions myopia institute:
interventions for controlling myopia onset and progression report[ J].
Invest Ophthalmol Vis Sci, 2019, 60(3): M106-M131.Wildsoet CF, Chia A, Cho P, et al. IMI - interventions myopia institute:
interventions for controlling myopia onset and progression report[ J].
Invest Ophthalmol Vis Sci, 2019, 60(3): M106-M131.
6、Wolffsohn JS, Kollbaum PS, Berntsen DA, et al. IMI - clinical myopia
control trials and instrumentation report. Invest Ophthalmol Vis Sci,
2019, 60(3): M132-M160.Wolffsohn JS, Kollbaum PS, Berntsen DA, et al. IMI - clinical myopia
control trials and instrumentation report. Invest Ophthalmol Vis Sci,
2019, 60(3): M132-M160.
7、Lau JK, Wan K, Cheung SW, et al. Weekly changes in axial length and
choroidal thickness in children during and following orthokeratology
treatment with different compression factors[ J]. Transl Vis Sci Technol,
2019, 8(4): 9.Lau JK, Wan K, Cheung SW, et al. Weekly changes in axial length and
choroidal thickness in children during and following orthokeratology
treatment with different compression factors[ J]. Transl Vis Sci Technol,
2019, 8(4): 9.
8、Ohno-Matsui K , Jonas JB. Posterior staphyloma in pathologic
myopia[ J]. Prog Retin Eye Res, 2019, 70(1): 99-109.Ohno-Matsui K , Jonas JB. Posterior staphyloma in pathologic
myopia[ J]. Prog Retin Eye Res, 2019, 70(1): 99-109.
9、Trivedi RH, Wilson ME. Axial length measurements by contact
and immersion techniques in pediatric eyes with cataract[ J].
Ophthalmology, 2011, 118(3): 498-502.Trivedi RH, Wilson ME. Axial length measurements by contact
and immersion techniques in pediatric eyes with cataract[ J].
Ophthalmology, 2011, 118(3): 498-502.
10、Ademola-Popoola DS, Nzeh DA, Saka SE, et al. Comparison of ocular
biometry measurements by applanation and immersion A-scan
techniques[ J]. J Curr Ophthalmol, 2016, 27(1): 110-114.Ademola-Popoola DS, Nzeh DA, Saka SE, et al. Comparison of ocular
biometry measurements by applanation and immersion A-scan
techniques[ J]. J Curr Ophthalmol, 2016, 27(1): 110-114.
11、Shajari M, Cremonese C, Petermann K, et al. Comparison of axial
length, corneal curvature, and anterior chamber depth measurements
of 2 recently introduced devices to a known biometer[ J]. Am J
Ophthalmol, 2017, 178(1): 58-64.Shajari M, Cremonese C, Petermann K, et al. Comparison of axial
length, corneal curvature, and anterior chamber depth measurements
of 2 recently introduced devices to a known biometer[ J]. Am J
Ophthalmol, 2017, 178(1): 58-64.
12、Shih KC, Chan TC, Ng AL, et al. Use of atropine for prevention of
childhood myopia progression in clinical practice[ J]. Eye Contact
Lens, 2016, 42(1): 16-23.Shih KC, Chan TC, Ng AL, et al. Use of atropine for prevention of
childhood myopia progression in clinical practice[ J]. Eye Contact
Lens, 2016, 42(1): 16-23.
13、Chia A , Lu QS, Tan D. Five-year clinical trial on atropine for
the treatment of myopia 2: myopia control with atropine 0.01%
eyedrops[ J]. Ophthalmology, 2016, 123(2): 391-399.Chia A , Lu QS, Tan D. Five-year clinical trial on atropine for
the treatment of myopia 2: myopia control with atropine 0.01%
eyedrops[ J]. Ophthalmology, 2016, 123(2): 391-399.
14、Jasvinder S, Khang TF, Sarinder KK, et al. Agreement analysis of
LENSTAR with other techniques of biometry[ J]. Eye (Lond), 2011,
25(6): 717-724.Jasvinder S, Khang TF, Sarinder KK, et al. Agreement analysis of
LENSTAR with other techniques of biometry[ J]. Eye (Lond), 2011,
25(6): 717-724.
15、Bach A, Villegas VM, Gold AS, et al. Axial length development in
children[ J]. Int J Ophthalmol, 2019, 12(5): 815-819.Bach A, Villegas VM, Gold AS, et al. Axial length development in
children[ J]. Int J Ophthalmol, 2019, 12(5): 815-819.
16、Yin G, Wang YX , Zheng ZY, et al. Ocular axial length and its
associations in Chinese: the Beijing Eye Study[ J]. PLoS One, 2012,
7(8): e43172.Yin G, Wang YX , Zheng ZY, et al. Ocular axial length and its
associations in Chinese: the Beijing Eye Study[ J]. PLoS One, 2012,
7(8): e43172.
17、Harb E, Hyman L, Gwiazda J, et al. Choroidal thickness profiles in
myopic eyes of young adults in the correction of myopia evaluation trial
cohort[ J]. Am J Ophthalmol, 2015, 160(1): 62-71.e2.Harb E, Hyman L, Gwiazda J, et al. Choroidal thickness profiles in
myopic eyes of young adults in the correction of myopia evaluation trial
cohort[ J]. Am J Ophthalmol, 2015, 160(1): 62-71.e2.
18、Flores-Moreno I, Lugo F, Duker JS, et al. The relationship between
axial length and choroidal thickness in eyes with high myopia[ J]. Am J
Ophthalmol, 2013, 155(2): 314-319.e1.Flores-Moreno I, Lugo F, Duker JS, et al. The relationship between
axial length and choroidal thickness in eyes with high myopia[ J]. Am J
Ophthalmol, 2013, 155(2): 314-319.e1.
19、Moderiano D, Do M, Hobbs S, et al. Influence of the time of day on
axial length and choroidal thickness changes to hyperopic and myopic
defocus in human eyes[ J]. Exp Eye Res, 2019, 182(1): 125-136.Moderiano D, Do M, Hobbs S, et al. Influence of the time of day on
axial length and choroidal thickness changes to hyperopic and myopic
defocus in human eyes[ J]. Exp Eye Res, 2019, 182(1): 125-136.
20、Lee SW, Yu SY, Seo KH, et al. Diurnal variation in choroidal thickness
in relation to sex, axial length, and baseline choroidal thickness in
healthy Korean subjects[ J]. Retina, 2014, 34(2): 385-393.Lee SW, Yu SY, Seo KH, et al. Diurnal variation in choroidal thickness
in relation to sex, axial length, and baseline choroidal thickness in
healthy Korean subjects[ J]. Retina, 2014, 34(2): 385-393.
21、Chakraborty R, Read SA, Collins MJ. Hyperopic defocus and diurnal
changes in human choroid and axial length[ J]. Optom Vis Sci, 2013,
90(11): 1187-1198.Chakraborty R, Read SA, Collins MJ. Hyperopic defocus and diurnal
changes in human choroid and axial length[ J]. Optom Vis Sci, 2013,
90(11): 1187-1198.
22、Chakraborty R, Read SA, Collins MJ. Diurnal variations in axial length,
choroidal thickness, intraocular pressure, and ocular biometrics[ J].
Invest Ophthalmol Vis Sci, 2011, 52(8): 5121-5129.Chakraborty R, Read SA, Collins MJ. Diurnal variations in axial length,
choroidal thickness, intraocular pressure, and ocular biometrics[ J].
Invest Ophthalmol Vis Sci, 2011, 52(8): 5121-5129.
23、Shum PJ, Ko LS, Ng CL, et al. A biometric study of ocular changes
during accommodation[ J]. Am J Ophthalmol, 1993, 115(1): 76-81.Shum PJ, Ko LS, Ng CL, et al. A biometric study of ocular changes
during accommodation[ J]. Am J Ophthalmol, 1993, 115(1): 76-81.
24、VanderVeen DK, Kraker RT, Pineles SL, et al. Use of orthokeratology
for the prevention of myopic progression in children: a report by the
American academy of ophthalmology[ J]. Ophthalmology, 2019,
126(4): 623-636.VanderVeen DK, Kraker RT, Pineles SL, et al. Use of orthokeratology
for the prevention of myopic progression in children: a report by the
American academy of ophthalmology[ J]. Ophthalmology, 2019,
126(4): 623-636.
